Health care stocks were flat to higher premarket Friday, with the iShares Biotechnology ETF (IBB) inactive and the Health Care Select Sector SPDR Fund (XLV) added 0.2% recently.
Moderna (MRNA) shares declined by over 4% after the company reported a swing to Q4 loss as revenue fell during the period.
NeuroPace (NPCE) shares fell by over 16% after the company priced a public offering of 6.5 million shares at $10 per share.
InflaRx (IFRX) slumped by more than 22% after the company priced an offering of 8.25 million ordinary shares at $2 apiece.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。